A disciplined, highly targeted approach to discovering new cancer medicines
Rigorous, definitive clinical trials based on deep oncology expertise
Committed to bringing differentiated new cancer medicines to patients
ARIAD's first internally discovered and developed medicine
ARIAD to Webcast Conference Call on First Quarter 2015 Financial Results
ARIAD Announces Issuance of Key U.S. Patent on Brigatinib
A shared commitment to patients and each other. This is ARIAD.